Skip to main content
Exact Dx synthetic data · demonstration

Staff surface Definitions and reviews

Definition library

Every executable definition and catalogue entry, with the threshold quoted from its source. All are drafts pending clinical and coding review; a definition shows as reviewed only after an approval is recorded. Default set library_default_set@1.0.

Coder worklist

Cancer-treatment adverse-event grading scale (NCI CTCAE): off by default

CTCAE grades describe adverse events in people receiving cancer treatment, usually in trials; they are not diagnostic criteria, and several grades depend on the laboratory reference range or on clinical descriptors that are not encoded. Using them outside that setting is a local decision for the clinical reviewer.

Current: Off (default) When on, grading entries are shown only as "another published definition gives …" or as values needing clinical judgement; they never raise a "not stated" item.

CDI or coding staff can change this setting and record reviews: switch the demo user.

1 of 66 shown.

COPD airflow obstruction grade by post-bronchodilator spirometry (GOLD 2026) gold2026_copd_airflow@1.0 1 Draft · pending review draft — pending clinical and coding review
Status
draft — pending clinical and coding review (draft — requires clinical and coding review)
Condition
Chronic obstructive pulmonary disease (spirometric grade)
Tier
1
Use here
default set (copd_airflow)
Edition
2026 report (2026)
Second source
none opened · not found: No independent second source (e.g. ATS/ERS) was opened.
Contested
yes: The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.

Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global Strategy for Prevention, Diagnosis and Management of COPD: 2026 Report — Pocket Guide

gold2026_copd_airflow@1.0
In patients with COPD (FEV1/FVC < 0.7): GOLD 1: Mild FEV1 ≥ 80% predicted; GOLD 2: Moderate 50% ≤ FEV1 < 80% predicted; GOLD 3: Severe 30% ≤ FEV1 < 50% predicted; GOLD 4: Very Severe FEV1 < 30% predicted

2026 report (2026) · Figure 2.10 (PDF page 20); key points (PDF page 11) · source

Review

No review recorded yet.